Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 71

Results For "Tech"

4276 News Found

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India
interviews | April 30, 2026

Our hybrid model combines global manufacturing with local clinical scale: Kavinder Beniwal, Chief Operational Officer, Motorica India

With the convergence of AI, robotics, and neuroscience, Motorica is advancing toward more intuitive, intent-driven prosthetic systems


Zealand Pharma and Roche charge into Phase 3 with obesity drug bet
Clinical Trials | April 30, 2026

Zealand Pharma and Roche charge into Phase 3 with obesity drug bet

The Danish biotech company confirmed the global study will begin in the second half of 2026


Monitra Health raises fresh funding  to scale upBeat® cardiac monitoring platform globally
Medical Device | April 30, 2026

Monitra Health raises fresh funding to scale upBeat® cardiac monitoring platform globally

The medtech firm strengthens its full-stack remote cardiac monitoring platform, achieves 11x revenue growth, and advances its global expansion plans


JP Nadda highlights India’s expanding healthcare ecosystem at PGIMER convocation
Policy | April 30, 2026

JP Nadda highlights India’s expanding healthcare ecosystem at PGIMER convocation

Union health minister urges graduates in Chandigarh to combine technological excellence with compassion in medical practice


BD, Suttons Creek partner to streamline combination product development
R&D | April 30, 2026

BD, Suttons Creek partner to streamline combination product development

The partnership integrates BD’s ZebraSci, a device-agnostic testing platform, with Suttons Creek’s expertise in combination product development and systems integration


Syngene reports FY26 revenue of Rs 3,739 Cr, up 3%; Q4 revenue at Rs 1,037 Cr
News | April 30, 2026

Syngene reports FY26 revenue of Rs 3,739 Cr, up 3%; Q4 revenue at Rs 1,037 Cr

Steady growth led by biologics and CRDMO business, EBITDA margin at 25% with continued investments in ADCs, peptides, and digital capabilities


Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout
News | April 30, 2026

Teva strikes $900M bet on breakthrough Tourette drug with Emalex buyout

The agreement could rise to $900 million if key commercial milestones are met


CPHI & PMEC India 2026 expand to dual venues in Delhi NCR
News | April 30, 2026

CPHI & PMEC India 2026 expand to dual venues in Delhi NCR

CPHI India from 23–25 November 2026 at Yashobhoomi (India International Convention and Expo Centre), while PMEC India from 24–26 November 2026 at India Expo Mart


India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework
Policy | April 30, 2026

India–New Zealand FTA elevates AYUSH systems to global stage with dedicated traditional medicine framework

Landmark agreement opens market access, mobility pathways, and institutional collaboration for Ayurveda, Yoga, and holistic healthcare services


Parexel acquires Vitrana to strengthen AI-driven patient safety capabilities
Clinical Trials | April 30, 2026

Parexel acquires Vitrana to strengthen AI-driven patient safety capabilities

Acquisition enhances integrated pharmacovigilance platform, combining AI, automation, and services to improve compliance, efficiency, and end-to-end clinical safety operations